Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1332

Oropharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Oropharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $2,000.00
Meta Description Oropharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis
Publisher GlobalData
Date of Report Jun 15, 2011
Quick Overview
Oropharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, “Oropharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Oropharyngeal Cancer Therapeutics market. The report identifies the key trends shaping and driving the global Oropharyngeal Cancer Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Oropharyngeal Cancer Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Oropharyngeal Cancer Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Oropharyngeal Cancer Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Oropharyngeal Cancer Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Oropharyngeal Cancer Therapeutics therapeutics market.
- Analysis of key recent licensing and partnership agreements in Oropharyngeal Cancer Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Oropharyngeal Cancer Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Oropharyngeal Cancer Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Oropharyngeal Cancer Therapeutics market landscape? – Identify, understand and capitalize.
Table of Contents
1 Table of contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Overview 6
2.2 Epidemiology 6
2.3 Etiology and Risk Factors 6
2.4 Signs and Symptoms 7
2.5 Diagnosis 7
2.6 Staging (TNM Classification) 8
2.7 Treatment 9
2.7.1 Treatment by stage of disease 11
2.8 GlobalData Pipeline Report Guidance 12
3 Oropharyngeal Cancer : Market Characterization 13
3.1 Major Markets, Market Size (2005-2010) 13
3.2 Major Markets, Market Forecast (2010-2017) 14
3.3 US Market Size (2005-2010) 16
3.4 US Market Forecast (2010-2017) 17
3.5 France Market Size (2005-2010) 18
3.6 France Market Forecast (2010-2017) 19
3.7 Germany Market Size (2005-2010) 20
3.8 Germany Market Forecast (2010-2017) 21
3.9 Italy Market Size (2005-2010) 22
3.10 Italy Market Forecast (2010-2017) 23
3.11 Spain Market Size (2005-2010) 24
3.12 Spain Market Forecast (2010-2017) 25
3.13 UK Market Size (2005-2010) 26
3.14 UK Market Forecast (2010-2017) 27
3.15 Japan Market Size (2005-2010) 28
3.16 Japan Market Forecast (2010-2017) 29
3.17 Drivers and Barriers for Oropharyngeal Cancer Therapeutic Market 30
3.17.1 Drivers for Oropharyngeal Cancer Market 30
3.17.2 Barriers for Oropharyngeal Cancer Market 30
3.18 Opportunity and Unmet Need 31
3.19 Key Takeaway 32
4 Oropharyngeal Cancer Market: Competitive Assessment 33
4.1 Overview 33
4.1.1 Strategic Competitor Assessment 33
4.2 Oropharyngeal Cancer Market Marketed products profile 34
4.2.1 Taxotere (docetaxel) 34
4.2.2 Erbitux (cetuximab) 35
4.2.3 Bleomycin 36
4.3 Key Takeaway 37
5 Oropharyngeal Cancer: Pipeline Assessment 38
5.1 Overview 38
5.2 Strategic Pipeline Assessment 38
5.3 Oropharyngeal Cancer Pipeline Analysis – Pipeline by Clinical Phases of Development 38
5.3.1 Oropharyngeal Cancer Therapeutics – Phase II Clinical Pipeline 38
5.4 Oropharyngeal Cancer Pipeline by Mechanism of Action 39
5.5 Oropharyngeal Cancer Technology Trends Analytical Framework 40
5.6 Oropharyngeal Cancer Clinical Pipeline by Monotherapy and Combination Therapy 41
5.7 Oropharyngeal Cancer Therapeutics – Promising Drugs under Clinical Development 41
5.8 Molecule Profile for Promising Drugs under Clinical Development 41
5.8.1 Vectibix (panitumumab) 41
5.9 Key Takeaway 42
6 Oropharyngeal Cancer – Clinical Trials Mapping 43
6.1 Clinical Trials Mapping by Region/Country 43
6.2 Clinical Trials Mapping by Phase 44
6.3 Clinical Trials Mapping by Trial Status 45
6.4 Clinical Trials Mapping by Sponsors 46
6.5 Participants in Therapeutic Clinical Trials – Companies 48
7 Oropharyngeal Cancer Therapeutics: Strategic Assessment 49
7.1 Key Events Impacting the Future Market 49
7.2 Future Market Competition Scenario 50
8 Global Oropharyngeal Cancer Therapeutics: Future Players in The Market 51
8.1 Introduction 51
8.2 Amgen Inc. 52
8.2.1 Company Overview 52
8.2.2 Financial Overview 52
8.2.3 Business Overview 53
9 Global Oropharyngeal Cancer Market: Appendix 56
9.1 Definitions 56
9.2 Acronyms 56
9.3 Research Methodology 57
9.3.1 Coverage 57
9.3.2 Secondary Research 58
9.3.3 Forecasting 58
9.3.4 Primary Research 60
9.3.5 Expert Panel Validation 61
9.4 Contact Us 61
9.5 Disclaimer 61
9.6 Bibliography 61




...